1362 / 1498
Lenalidomide
Chanan-Khan, A. A. et al. J Clin Oncol; 26:1544-1552 2008
►
Immunomodulatory
properties
►
Modulation of both cellular
and cytokine tumour cell
microenvironment
►
Activates T cell and NK
response to tumour cell
►
Down regulates pro-survival
cytokines
►
Approval in myeloma